Your browser doesn't support javascript.
loading
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.
Bansi-Matharu, Loveleen; Phillips, Andrew; Oprea, Cristiana; Grabmeier-Pfistershammer, Katharina; Günthard, Huldrych F; De Wit, Stephane; Guaraldi, Giovanni; Vehreschild, Jorg J; Wit, Ferdinand; Law, Matthew; Wasmuth, Jan-Christian; Chkhartishvili, Nikoloz; d'Arminio Monforte, Antonella; Fontas, Eric; Vesterbacka, Jan; Miro, Jose M; Castagna, Antonella; Stephan, Christoph; Llibre, Josep M; Neesgaard, Bastian; Greenberg, Lauren; Smith, Colette; Kirk, Ole; Duvivier, Claudine; Dragovic, Gordana; Lundgren, Jens; Dedes, Nikos; Knudsen, Andreas; Gallant, Joel; Vannappagari, Vani; Peters, Lars; Elbirt, Daniel; Sarcletti, Mario; Braun, Dominique L; Necsoi, Coca; Mussini, Cristina; Muccini, Camilla; Bolokadze, Natalie; Hoy, Jennifer; Mocroft, Amanda; Ryom, Lene.
Afiliación
  • Bansi-Matharu L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK. Electronic address: l.bansi-matharu@ucl.ac.uk.
  • Phillips A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK.
  • Oprea C; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
  • Grabmeier-Pfistershammer K; Austrian HIV Cohort Study, Department of Dermatology and Venerology, Medical University Innsbruck, Innsbruck, Austria.
  • Günthard HF; Swiss HIV Cohort Study, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • De Wit S; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Guaraldi G; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Vehreschild JJ; University Hospital Cologne, Cologne, Germany.
  • Wit F; AIDS Therapy Evaluation in the Netherlands cohort, HIV Monitoring Foundation, Amsterdam, Netherlands.
  • Law M; The Australian HIV Observational Database, University of New South Wales, Sydney, NSW, Australia.
  • Wasmuth JC; University Hospital Bonn, Bonn, Germany.
  • Chkhartishvili N; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
  • d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals, ASST Santi Paolo e Carlo, Milan, Italy.
  • Fontas E; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
  • Vesterbacka J; Swedish InfCare HIV Cohort, Karolinska University Hospital, Huddinge, Sweden.
  • Miro JM; Infectious Diseases Service. Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
  • Stephan C; Frankfurt HIV Cohort Study, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany.
  • Llibre JM; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Fight AIDS Foundation, Badalona, Barcelona, Spain.
  • Neesgaard B; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK.
  • Smith C; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK.
  • Kirk O; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; COCOMO, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Duvivier C; AP-HP-Necker-Enfants Malades Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Center, IHU Imagine, Institut Cochin- CNRS 8104-INSERM U1016-Retrovirus, Infection and Latency Team, University of Paris, Institut Pasteur, Medical Center of Institut Pasteur, Paris, France.
  • Dragovic G; Institute of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Lundgren J; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Dedes N; European AIDS Treatment Group, Brussels, Belgium.
  • Knudsen A; COCOMO, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Gallant J; Gilead Sciences, Foster City, CA, USA.
  • Vannappagari V; ViiV Healthcare, Research Triangle, NC, USA.
  • Peters L; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Elbirt D; Allergy, Immunology and HIV Unit, Kaplan Medical Center, Rehovot, Israel.
  • Sarcletti M; Austrian HIV Cohort Study, Department of Dermatology and Venerology, Medical University Innsbruck, Innsbruck, Austria.
  • Braun DL; Swiss HIV Cohort Study, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Necsoi C; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Muccini C; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
  • Bolokadze N; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
  • Hoy J; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Ryom L; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lancet HIV ; 8(11): e711-e722, 2021 11.
Article en En | MEDLINE | ID: mdl-34555326
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Aumento de Peso / Infecciones por VIH / VIH-1 / Antirretrovirales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Aumento de Peso / Infecciones por VIH / VIH-1 / Antirretrovirales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa / Oceania Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article